Edison Investment Research - Kongsberg Automotive ASA (KOA) Update: Q3 wins highlight strategy

Report

Edison Investment Research

Update: Q3 wins highlight strategy

Kongsberg Automotiveâ€™s (KA) Q3 results highlighted that the business is resilient in the face of market uncertainty and is successful in gaining technologically-driven wins. The focus remains on delivering improved returns through higher-margin contracts and improved asset utilisation. An example of this is KAâ€™s downscaling of production at its Rollag, Norway, facility by 2018, outsourcing production of high manual content forgings and focusing on higher value-added machining. The group is also investing in R&D, as shown by several significant wins in Q3 and the opening of a new Driveline technology centre.

24/10/2014 6 EN

Underlying

Kongsberg Automotive ASA

Kongsberg Automotive develops, manufactures and sells products to the automotive industry worldwide. The product portfolio includes seat comfort systems, driveline related systems, fluid assemblies, and industrial driver-interface products developed for vehicle manufacturers. Co.'s business area focus on interior, which provides safety and comfort related products; driveline, which provides gear shift systems for light duty vehicles; fluid transfer, which provides fluid handling systems for commercial vehicles and passenger cars; and driver control, which provides driver control systems and chassis related products to commercial vehicles, outdoor power equipment and recreational products.

See profile

NO0003033102 Oslo Bors Norway

Provider

Edison Investment Research

Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

See profile

Other Reports on these Companies

SmartInsider

Kongsberg Automotive ASA: 1 director

A director at Kongsberg Automotive ASA bought 582,087 shares at 1.411NOK and the significance rating of the trade was 40/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The na...

Free Trial

March 14, 2024 March 14, 2024 1 EN

Ford Equity Research

Ford Equity International Rating and Forecast Report

Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stockâ€™s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the we...

EUR 18.48

December 16, 2016 December 16, 2016 2 EN

Edison Investment Research

Update: Q1 shows good order wins

Kongsberg Automotiveâ€™s (KA) Q1 results demonstrated that the group continues to make progress in new order wins, with annualised contract wins of â‚¬53m in Q1 equating to a 12-month rolling run rate of â‚¬293m, which supports managementâ€™s target of 3-5% organic growth within three years. Revenues were c 6% ahead of Q114 due to currency effects and the R&D costs were in line with expectations. We therefore maintain our forecasts and anticipate progressively improving margins over the course of the year to achieve the 6% level required to hit the 13% ROCE target.

April 22, 2015 April 22, 2015 3 EN

Basilea Pharmaceutica - Cresemba milestone payments continue to roll in

Basilea Pharmaceutica has announced the triggering of a US$1.25m milestone payment from Pfizer, triggered by sustained strong sales of Cresemba in the Asia-Pacific region and China. This is the second FY24 milestone payment for the region and is incremental to the payment received in March. We note that, according to the latest available data, total in-market sales of Cresemba amounted to US$473m in the 12 months ending December 2023, representing a +26% year-on-year increase. Basilea is preparing to launch its Phase III programme for fosmanogepix, a broad-spectrum antifungal therapy, with the...

May 17, 2024 May 17, 2024 1 EN

Toby Thorrington

Toby Thorrington

AAC Clyde Space - Solid start to the year with further order growth

AAC Clyde Space offers exposure to the fast-growing low Earth orbit space market. A solid start to the year and continued order momentum are encouraging. We also note the internal restructuring to promote delivery of the group’s products and services. We expect this combination to drive an improving performance, albeit within the lumpy nature of the business, in turn improving investor confidence and the stock’s valuation.

May 17, 2024 May 17, 2024 1 EN

Richard Williamson

Richard Williamson

Tinexta - Typical seasonality in Q124

Tinexta’s Q124 results showed good progress in the two divisions that typically demonstrate more consistent (through the year) growth, Cyber Security and Digital Trust, which management expects to deliver higher growth over the next few years. Business Innovation demonstrated its typical seasonality and management therefore remains confident about the outlook for the year.

May 17, 2024 May 17, 2024 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Update: Q3 wins highlight strategy

Kongsberg Automotive ASA: 1 director

Ford Equity International Rating and Forecast Report

Update: Q1 shows good order wins

Basilea Pharmaceutica - Cresemba milestone payments continue to roll in

AAC Clyde Space - Solid start to the year with further order growth

Tinexta - Typical seasonality in Q124

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe